These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 21045016)
41. Capn4 contributes to tumor invasion and metastasis in clear cell renal cell carcinoma cells via modulating talin-focal adhesion kinase signaling pathway. Zhuang Q; Luo W; Zhang M; Fan M; Lu H; Xu R; He X Acta Biochim Biophys Sin (Shanghai); 2018 May; 50(5):465-472. PubMed ID: 29648579 [TBL] [Abstract][Full Text] [Related]
42. Involvement of transforming growth factor beta 1 in the transcriptional regulation of nicotinamide N-methyltransferase in clear cell renal cell carcinoma. Campagna R; Cecati M; Pozzi V; Fumarola S; Pompei V; Milanese G; Galosi AB; Sartini D; Emanuelli M Cell Mol Biol (Noisy-le-grand); 2018 May; 64(7):51-55. PubMed ID: 29974846 [TBL] [Abstract][Full Text] [Related]
43. Expression of the PTTG1 oncogene is associated with aggressive clear cell renal cell carcinoma. Wondergem B; Zhang Z; Huang D; Ong CK; Koeman J; Hof DV; Petillo D; Ooi A; Anema J; Lane B; Kahnoski RJ; Furge KA; Teh BT Cancer Res; 2012 Sep; 72(17):4361-71. PubMed ID: 22805307 [TBL] [Abstract][Full Text] [Related]
44. Histone deacetylase inhibitor depsipeptide represses nicotinamide N-methyltransferase and hepatocyte nuclear factor-1beta gene expression in human papillary thyroid cancer cells. Xu J; Hershman JM Thyroid; 2006 Feb; 16(2):151-60. PubMed ID: 16676400 [TBL] [Abstract][Full Text] [Related]
45. HDAC 1 and 6 modulate cell invasion and migration in clear cell renal cell carcinoma. Ramakrishnan S; Ku S; Ciamporcero E; Miles KM; Attwood K; Chintala S; Shen L; Ellis L; Sotomayor P; Swetzig W; Huang R; Conroy D; Orillion A; Das G; Pili R BMC Cancer; 2016 Aug; 16():617. PubMed ID: 27506904 [TBL] [Abstract][Full Text] [Related]
46. Inhibiting proliferation in KB cancer cells by RNA interference-mediated knockdown of nicotinamide N-methyltransferase expression. Pozzi V; Mazzotta M; Lo Muzio L; Sartini D; Santarelli A; Renzi E; Rocchetti R; Tomasetti M; Ciavarella D; Emanuelli M Int J Immunopathol Pharmacol; 2011; 24(1):69-77. PubMed ID: 21496389 [TBL] [Abstract][Full Text] [Related]
47. Altered levels of acid, basic, and neutral peptidase activity and expression in human clear cell renal cell carcinoma. Varona A; Blanco L; López JI; Gil J; Agirregoitia E; Irazusta J; Larrinaga G Am J Physiol Renal Physiol; 2007 Feb; 292(2):F780-8. PubMed ID: 16985214 [TBL] [Abstract][Full Text] [Related]
48. Nicotinamide-N-methyltransferase is a promising metabolic drug target for primary and metastatic clear cell renal cell carcinoma. Reustle A; Menig LS; Leuthold P; Hofmann U; Stühler V; Schmees C; Becker M; Haag M; Klumpp V; Winter S; Büttner FA; Rausch S; Hennenlotter J; Fend F; Scharpf M; Stenzl A; Bedke J; Schwab M; Schaeffeler E Clin Transl Med; 2022 Jun; 12(6):e883. PubMed ID: 35678045 [TBL] [Abstract][Full Text] [Related]
49. ETV4 is a theranostic target in clear cell renal cell carcinoma that promotes metastasis by activating the pro-metastatic gene FOSL1 in a PI3K-AKT dependent manner. Xu L; Hu H; Zheng LS; Wang MY; Mei Y; Peng LX; Qiang YY; Li CZ; Meng DF; Wang MD; Liu ZJ; Li XJ; Huang BJ; Qian CN Cancer Lett; 2020 Jul; 482():74-89. PubMed ID: 32305558 [TBL] [Abstract][Full Text] [Related]
50. G6PD facilitates clear cell renal cell carcinoma invasion by enhancing MMP2 expression through ROS‑MAPK axis pathway. Zhang Q; Han Q; Yang Z; Ni Y; Agbana YL; Bai H; Yi Z; Yi X; Kuang Y; Zhu Y Int J Oncol; 2020 Jul; 57(1):197-212. PubMed ID: 32319593 [TBL] [Abstract][Full Text] [Related]
52. Membrane-type 1 matrix metalloproteinase is regulated by sp1 through the differential activation of AKT, JNK, and ERK pathways in human prostate tumor cells. Sroka IC; Nagle RB; Bowden GT Neoplasia; 2007 May; 9(5):406-17. PubMed ID: 17534446 [TBL] [Abstract][Full Text] [Related]
53. Nicotinamide N-methyltransferase protein expression in renal cell cancer. Zhang J; Xie XY; Yang SW; Wang J; He C J Zhejiang Univ Sci B; 2010 Feb; 11(2):136-43. PubMed ID: 20104648 [TBL] [Abstract][Full Text] [Related]
54. Nicotinamide N-methyltransferase enhances the capacity of tumorigenesis associated with the promotion of cell cycle progression in human colorectal cancer cells. Xie X; Yu H; Wang Y; Zhou Y; Li G; Ruan Z; Li F; Wang X; Liu H; Zhang J Arch Biochem Biophys; 2014 Dec; 564():52-66. PubMed ID: 25201588 [TBL] [Abstract][Full Text] [Related]
55. Role of nicotinamide N-methyltransferase in non-small cell lung cancer: in vitro effect of shRNA-mediated gene silencing on tumourigenicity. Sartini D; Seta R; Pozzi V; Morganti S; Rubini C; Zizzi A; Tomasetti M; Santarelli L; Emanuelli M Biol Chem; 2015 Mar; 396(3):225-34. PubMed ID: 25204218 [TBL] [Abstract][Full Text] [Related]
57. Co-existence of high levels of the PTEN protein with enhanced Akt activation in renal cell carcinoma. He L; Fan C; Gillis A; Feng X; Sanatani M; Hotte S; Kapoor A; Tang D Biochim Biophys Acta; 2007 Oct; 1772(10):1134-42. PubMed ID: 17681738 [TBL] [Abstract][Full Text] [Related]
58. Nicotinamide N-methyltransferase enhances chemoresistance in breast cancer through SIRT1 protein stabilization. Wang Y; Zeng J; Wu W; Xie S; Yu H; Li G; Zhu T; Li F; Lu J; Wang GY; Xie X; Zhang J Breast Cancer Res; 2019 May; 21(1):64. PubMed ID: 31101119 [TBL] [Abstract][Full Text] [Related]
59. Nicotinamide N‑methyltransferase induces the proliferation and invasion of squamous cell carcinoma cells. Hah YS; Cho HY; Jo SY; Park YS; Heo EP; Yoon TJ Oncol Rep; 2019 Nov; 42(5):1805-1814. PubMed ID: 31545452 [TBL] [Abstract][Full Text] [Related]
60. Expression of RSK4, CD44 and MMP-9 is upregulated and positively correlated in metastatic ccRCC. Ma J; Li M; Chai J; Wang K; Li P; Liu Y; Zhao D; Xu J; Yu K; Yan Q; Guo S; Wang Z; Fan L Diagn Pathol; 2020 Mar; 15(1):28. PubMed ID: 32209138 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]